CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Positive Psychology Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05147311
NCT05147311N/ACompleted

Randomized Trial of a Positive Psychology Intervention for Patients With Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation

Brigham and Women's Hospital·interventional·Posted Dec 7, 2021·Updated Jul 30, 2024

In Brief

A clinical study evaluating Positive Psychology Intervention for Hematologic Malignancy and 2 related conditions. Completed, enrolled 72 participants across 1 site.

Detailed Summary

The main purpose of this research study is to determine if a positive psychology-based program in people who have received a stem cell transplant for blood cancer treatment is feasible and acceptable, and can help improve positive feelings, mood, quality of life, overall wellbeing and health. The Positive psychology for Allogenic Transplantation of Hematopoietic stem cell intervention (PATH), a novel 9-week phone-administered Positive psychological intervention (PPI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 7, 2021
Enrollment StartNov 17, 2021
Primary CompletionMay 16, 2023
Study CompletionAug 28, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.6 years ago

Interventions

Positive Psychology Interventionbehavioral

Weekly phone calls with the study interventionist and positive psychology exercises over an 9-week period. The positive psychology program exercises include three modules: gratitude-based activities, strength-based activities, and meaning-based activities.